Lantern Pharma Inc.
LTRN
$3.16
-$0.03-0.94%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -48.59% | -41.86% | -37.55% | -30.63% | -25.58% |
Total Receivables | -- | -88.72% | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -18.25% | -3.51% | -34.30% | -41.12% | -51.78% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 32.63% | -- | -6.15% | -24.24% | -82.06% |
Total Current Assets | -47.24% | -41.75% | -36.91% | -30.86% | -28.45% |
|
|||||
Total Current Assets | -47.24% | -41.75% | -36.91% | -30.86% | -28.45% |
Net Property, Plant & Equipment | -0.55% | 2.50% | 4.97% | -26.49% | -23.09% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 41.70% | 41.70% | 41.70% | 23.55% | -21.52% |
Total Assets | -46.91% | -41.41% | -36.59% | -30.80% | -28.42% |
|
|||||
Total Accounts Payable | 81.46% | 156.36% | 62.42% | 42.58% | 35.88% |
Total Accrued Expenses | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -9.27% | 10.29% | 17.44% | 0.55% | 48.83% |
Total Finance Division Other Current Liabilities | -44.57% | 10.36% | 65.70% | 74.55% | 45.46% |
Total Other Current Liabilities | -44.57% | 10.36% | 65.70% | 74.55% | 45.46% |
Total Current Liabilities | 8.42% | 61.72% | 59.81% | 52.55% | 41.54% |
|
|||||
Total Current Liabilities | 8.42% | 61.72% | 59.81% | 52.55% | 41.54% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 114.10% | -14.15% | -11.74% | -63.70% | -88.90% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 8.84% | 60.02% | 56.58% | 47.01% | 35.29% |
|
|||||
Common Stock & APIC | 0.79% | 0.83% | 0.17% | 0.17% | 0.44% |
Retained Earnings | -32.75% | -37.62% | -37.39% | -37.05% | -40.64% |
Treasury Stock & Other | 6,831.58% | 243.26% | 81.77% | 97.48% | 100.63% |
Total Common Equity | -53.09% | -48.21% | -41.43% | -35.91% | -31.97% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -53.09% | -48.21% | -41.43% | -35.91% | -31.97% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -53.09% | -48.21% | -41.43% | -35.91% | -31.97% |
|